HEADER GENE REGULATION 22-AUG-17 5Y95 TITLE HADDOCK MODEL OF MSIN3B PAH1 DOMAIN COMPND MOL_ID: 1; COMPND 2 MOLECULE: PAIRED AMPHIPATHIC HELIX PROTEIN SIN3B; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: UNP RESIDUES 32-98; COMPND 5 SYNONYM: HISTONE DEACETYLASE COMPLEX SUBUNIT SIN3B,TRANSCRIPTIONAL COMPND 6 COREPRESSOR SIN3B; COMPND 7 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: MUS MUSCULUS; SOURCE 3 ORGANISM_COMMON: MOUSE; SOURCE 4 ORGANISM_TAXID: 10090; SOURCE 5 GENE: SIN3B, KIAA0700; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21(DE3); SOURCE 7 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: BL21(DE3) KEYWDS HADDOCK MODEL, COMPLEX, GENE REGULATION EXPDTA SOLUTION NMR NUMMDL 10 AUTHOR J.KURITA,Y.HIRAO,Y.NISHIMURA REVDAT 4 29-MAY-24 5Y95 1 REMARK REVDAT 3 14-JUN-23 5Y95 1 REMARK REVDAT 2 06-DEC-17 5Y95 1 JRNL REVDAT 1 04-OCT-17 5Y95 0 JRNL AUTH H.UEDA,J.I.KURITA,H.NEYAMA,Y.HIRAO,H.KOUJI,T.MISHINA, JRNL AUTH 2 M.KASAI,H.NAKANO,A.YOSHIMORI,Y.NISHIMURA JRNL TITL A MIMETIC OF THE MSIN3-BINDING HELIX OF NRSF/REST JRNL TITL 2 AMELIORATES ABNORMAL PAIN BEHAVIOR IN CHRONIC PAIN MODELS. JRNL REF BIOORG. MED. CHEM. LETT. V. 27 4705 2017 JRNL REFN ESSN 1464-3405 JRNL PMID 28927787 JRNL DOI 10.1016/J.BMCL.2017.09.006 REMARK 2 REMARK 2 RESOLUTION. NOT APPLICABLE. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : HADDOCK REMARK 3 AUTHORS : BONVIN REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 5Y95 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBJ ON 20-SEP-17. REMARK 100 THE DEPOSITION ID IS D_1300004855. REMARK 210 REMARK 210 EXPERIMENTAL DETAILS REMARK 210 EXPERIMENT TYPE : NMR REMARK 210 TEMPERATURE (KELVIN) : 298 REMARK 210 PH : 7.2 REMARK 210 IONIC STRENGTH : 100 REMARK 210 PRESSURE : 1 ATM REMARK 210 SAMPLE CONTENTS : 100 UM [U-99% 15N] MSIN3B, 100 REMARK 210 MM SODIUM PHOSPHATE, 95% H2O/5% REMARK 210 DMSO REMARK 210 REMARK 210 NMR EXPERIMENTS CONDUCTED : 2D 1H-15N HSQC REMARK 210 SPECTROMETER FIELD STRENGTH : 700 MHZ REMARK 210 SPECTROMETER MODEL : AVANCE III HD REMARK 210 SPECTROMETER MANUFACTURER : BRUKER REMARK 210 REMARK 210 STRUCTURE DETERMINATION. REMARK 210 SOFTWARE USED : NMRVIEW REMARK 210 METHOD USED : MOLECULAR DYNAMICS REMARK 210 REMARK 210 CONFORMERS, NUMBER CALCULATED : 200 REMARK 210 CONFORMERS, NUMBER SUBMITTED : 10 REMARK 210 CONFORMERS, SELECTION CRITERIA : STRUCTURES WITH THE LOWEST REMARK 210 ENERGY REMARK 210 REMARK 210 BEST REPRESENTATIVE CONFORMER IN THIS ENSEMBLE : 1 REMARK 210 REMARK 210 REMARK: NULL REMARK 215 REMARK 215 NMR STUDY REMARK 215 THE COORDINATES IN THIS ENTRY WERE GENERATED FROM SOLUTION REMARK 215 NMR DATA. PROTEIN DATA BANK CONVENTIONS REQUIRE THAT REMARK 215 CRYST1 AND SCALE RECORDS BE INCLUDED, BUT THE VALUES ON REMARK 215 THESE RECORDS ARE MEANINGLESS. REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 OE2 GLU A 60 HZ1 LYS A 63 1.59 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 1 PHE A 48 44.18 -106.94 REMARK 500 1 ASP A 71 -162.46 -110.00 REMARK 500 1 PHE A 83 47.61 -94.96 REMARK 500 1 PHE A 96 31.57 -89.35 REMARK 500 2 PHE A 48 40.02 -103.59 REMARK 500 2 PHE A 83 48.74 -91.50 REMARK 500 3 SER A 27 73.17 -101.12 REMARK 500 3 ASP A 71 -151.20 -136.30 REMARK 500 3 PHE A 83 41.90 -90.89 REMARK 500 4 PHE A 48 41.76 -107.19 REMARK 500 4 ASP A 71 -163.25 -106.85 REMARK 500 5 PHE A 48 54.65 -104.27 REMARK 500 5 ASP A 71 -166.48 -123.12 REMARK 500 5 PHE A 83 44.52 -97.57 REMARK 500 6 ASP A 71 -158.93 -119.17 REMARK 500 6 PHE A 83 45.59 -101.18 REMARK 500 6 PRO A 101 39.38 -79.98 REMARK 500 7 ASP A 71 -164.49 -107.37 REMARK 500 7 PHE A 83 32.24 -97.08 REMARK 500 8 ASP A 71 -165.55 -114.35 REMARK 500 8 PHE A 83 45.27 -93.11 REMARK 500 8 PHE A 96 44.50 -97.26 REMARK 500 9 GLU A 35 56.75 -102.60 REMARK 500 9 PHE A 48 54.03 -102.35 REMARK 500 9 PHE A 83 43.77 -103.82 REMARK 500 10 SER A 29 85.57 -151.41 REMARK 500 10 PHE A 48 58.94 -107.40 REMARK 500 10 ASP A 71 -164.35 -105.30 REMARK 500 10 PHE A 83 38.90 -91.29 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue 8TL A 201 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 27227 RELATED DB: BMRB REMARK 900 RELATED ID: 2CR7 RELATED DB: PDB DBREF 5Y95 A 32 98 UNP Q62141 SIN3B_MOUSE 32 98 SEQADV 5Y95 GLY A 25 UNP Q62141 EXPRESSION TAG SEQADV 5Y95 SER A 26 UNP Q62141 EXPRESSION TAG SEQADV 5Y95 SER A 27 UNP Q62141 EXPRESSION TAG SEQADV 5Y95 GLY A 28 UNP Q62141 EXPRESSION TAG SEQADV 5Y95 SER A 29 UNP Q62141 EXPRESSION TAG SEQADV 5Y95 SER A 30 UNP Q62141 EXPRESSION TAG SEQADV 5Y95 GLY A 31 UNP Q62141 EXPRESSION TAG SEQADV 5Y95 SER A 99 UNP Q62141 EXPRESSION TAG SEQADV 5Y95 GLY A 100 UNP Q62141 EXPRESSION TAG SEQADV 5Y95 PRO A 101 UNP Q62141 EXPRESSION TAG SEQADV 5Y95 SER A 102 UNP Q62141 EXPRESSION TAG SEQADV 5Y95 SER A 103 UNP Q62141 EXPRESSION TAG SEQADV 5Y95 GLY A 104 UNP Q62141 EXPRESSION TAG SEQRES 1 A 80 GLY SER SER GLY SER SER GLY VAL HIS VAL GLU ASP ALA SEQRES 2 A 80 LEU THR TYR LEU ASP GLN VAL LYS ILE ARG PHE GLY SER SEQRES 3 A 80 ASP PRO ALA THR TYR ASN GLY PHE LEU GLU ILE MET LYS SEQRES 4 A 80 GLU PHE LYS SER GLN SER ILE ASP THR PRO GLY VAL ILE SEQRES 5 A 80 ARG ARG VAL SER GLN LEU PHE HIS GLU HIS PRO ASP LEU SEQRES 6 A 80 ILE VAL GLY PHE ASN ALA PHE LEU PRO SER GLY PRO SER SEQRES 7 A 80 SER GLY HET 8TL A 201 29 HETNAM 8TL PROPAN-2-YL (3R,6S,9AS)-3-ETHYL-8-(3-METHYLBUTYL)-6-(2- HETNAM 2 8TL METHYLSULFANYLETHYL)-4,7-BIS(OXIDANYLIDENE)-9,9A- HETNAM 3 8TL DIHYDRO-6H-PYRAZINO[2,1-C][1,2,4]OXADIAZINE-1- HETNAM 4 8TL CARBOXYLATE FORMUL 2 8TL C20 H35 N3 O5 S HELIX 1 AA1 ASP A 36 PHE A 48 1 13 HELIX 2 AA2 ASP A 51 SER A 67 1 17 HELIX 3 AA3 ASP A 71 PHE A 83 1 13 HELIX 4 AA4 HIS A 86 PHE A 96 1 11 SITE 1 AC1 10 ALA A 37 TYR A 40 LEU A 41 PHE A 58 SITE 2 AC1 10 PHE A 65 THR A 72 VAL A 75 VAL A 79 SITE 3 AC1 10 PHE A 93 PHE A 96 CRYST1 1.000 1.000 1.000 90.00 90.00 90.00 P 1 1 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 1.000000 0.000000 0.000000 0.00000 SCALE2 0.000000 1.000000 0.000000 0.00000 SCALE3 0.000000 0.000000 1.000000 0.00000 MODEL 1